Clinical Trial Update: Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and pharmacokinetics of bedaquiline and delamanid, alone and in combination, for drug-resistant pulmonary tubercu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Delamanid (delamanid)
• bedaquiline (bedaquiline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-01-29